Arovella Therapeutics Limited (AU:ALA) has released an update.
Arovella Therapeutics Limited has released its corporate governance statement for the fiscal year ended 30 June 2024, confirming adherence to the ASX Corporate Governance Council’s recommendations. The detailed governance documentation is publicly accessible on the company’s website, ensuring transparency and accountability. The statement, approved by the board, demonstrates Arovella’s commitment to robust governance practices.
For further insights into AU:ALA stock, check out TipRanks’ Stock Analysis page.
